title: Advances in cardiac ATP-sensitive K+ channelopathies from molecules to populations.
authors.affiliation: Marriott Heart Disease Research Program, Division of Cardiovascular Diseases, Department of Internal Medicine, Department of Molecular Pharmacology and Experimental Therapeutics, Department of Medical Genetics, Mayo Clinic, Rochester, MN, USA. terzic.andre@mayo.edu
authors.forename: Andre
authors.initials: A
authors.lastname: Terzic
authors.forename: Alexey E
authors.initials: AE
authors.lastname: Alekseev
authors.forename: Satsuki
authors.initials: S
authors.lastname: Yamada
authors.forename: Santiago
authors.initials: S
authors.lastname: Reyes
authors.forename: Timothy M
authors.initials: TM
authors.lastname: Olson
mesh_terms: D001281:Atrial Fibrillation / Q000209:etiology / Q000235:genetics / Q000378:metabolism; D002311:Cardiomyopathy, Dilated / Q000209:etiology / Q000235:genetics / Q000378:metabolism; D053447:Channelopathies / Q000150:complications / Q000235:genetics* / Q000378:metabolism*; D014644:Genetic Variation / Q000235:genetics*; D006333:Heart Failure / Q000209:etiology / Q000235:genetics / Q000378:metabolism; D006801:Humans; D054086:KATP Channels / Q000235:genetics* / Q000378:metabolism*; D009203:Myocardial Infarction / Q000209:etiology / Q000235:genetics / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism*; D017180:Tachycardia, Ventricular / Q000209:etiology / Q000235:genetics / Q000378:metabolism
chemical_list: D054086:KATP Channels